|
regulation of mrna processing
|
GO:0050684 |
3 |
0.139
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.070
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.061
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.054
|
|
|
aging
|
GO:0007568 |
2 |
0.047
|
|
|
female gonad development
|
GO:0008585 |
4 |
0.036
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.032
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
3 |
0.030
|
|
|
female sex differentiation
|
GO:0046660 |
4 |
0.027
|
|
|
stem cell maintenance
|
GO:0019827 |
4 |
0.026
|
|
|
gene silencing by rna
|
GO:0031047 |
4 |
0.026
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.025
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.025
|
|
|
regionalization
|
GO:0003002 |
274 |
0.024
|
|
|
nuclear import
|
GO:0051170 |
3 |
0.024
|
|
|
single organism nuclear import
|
GO:1902593 |
3 |
0.024
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.023
|
|
|
protein import
|
GO:0017038 |
3 |
0.023
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
3 |
0.023
|
|
|
gene silencing
|
GO:0016458 |
4 |
0.023
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.023
|
|
|
positive regulation of cellular process
|
GO:0048522 |
201 |
0.023
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
3 |
0.022
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.022
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.021
|
|
|
immune system process
|
GO:0002376 |
241 |
0.020
|
|
|
protein import into nucleus
|
GO:0006606 |
3 |
0.020
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
3 |
0.020
|
|
|
regulation of dna replication
|
GO:0006275 |
3 |
0.020
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
4 |
0.019
|
|
|
protein targeting to nucleus
|
GO:0044744 |
3 |
0.019
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.019
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.018
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.018
|
|
|
embryonic skeletal system development
|
GO:0048706 |
97 |
0.017
|
|
|
response to drug
|
GO:0042493 |
3 |
0.017
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.016
|
|
|
rna processing
|
GO:0006396 |
25 |
0.016
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
4 |
0.016
|
|
|
gene expression
|
GO:0010467 |
252 |
0.016
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.015
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.015
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
2 |
0.015
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.015
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
1 |
0.015
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
4 |
0.015
|
|
|
regulation of multicellular organism growth
|
GO:0040014 |
4 |
0.015
|
|
|
response to stress
|
GO:0006950 |
263 |
0.015
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
1 |
0.014
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.014
|
|
|
larval development
|
GO:0002164 |
2 |
0.014
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
2 |
0.014
|
|
|
multicellular organism growth
|
GO:0035264 |
4 |
0.014
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
4 |
0.014
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.014
|
|
|
lateral line development
|
GO:0048882 |
66 |
0.013
|
|
|
immune system development
|
GO:0002520 |
191 |
0.013
|
|
|
response to chemical
|
GO:0042221 |
320 |
0.013
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.013
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.013
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
1 |
0.012
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.012
|
|
|
amine metabolic process
|
GO:0009308 |
2 |
0.012
|
|
|
gland development
|
GO:0048732 |
143 |
0.012
|
|
|
convergent extension
|
GO:0060026 |
118 |
0.012
|
|
|
regulation of cell shape
|
GO:0008360 |
1 |
0.012
|
|
|
regulation of protein transport
|
GO:0051223 |
3 |
0.012
|
|
|
regulation of tube size
|
GO:0035150 |
2 |
0.012
|
|
|
cellular amine metabolic process
|
GO:0044106 |
2 |
0.012
|
|
|
response to other organism
|
GO:0051707 |
97 |
0.012
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.012
|
|
|
meiosis i
|
GO:0007127 |
1 |
0.012
|
|
|
macromolecular complex subunit organization
|
GO:0043933 |
74 |
0.012
|
|
|
phosphate containing compound metabolic process
|
GO:0006796 |
108 |
0.011
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
3 |
0.011
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
4 |
0.011
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
125 |
0.011
|
|
|
mrna processing
|
GO:0006397 |
14 |
0.011
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
4 |
0.011
|
|
|
response to external biotic stimulus
|
GO:0043207 |
97 |
0.011
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.011
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.011
|
|
|
negative regulation of tor signaling
|
GO:0032007 |
2 |
0.011
|
|
|
cellular response to radiation
|
GO:0071478 |
4 |
0.011
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
3 |
0.011
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
1 |
0.011
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.011
|
|
|
oxoacid metabolic process
|
GO:0043436 |
31 |
0.010
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
4 |
0.010
|
|
|
b cell activation
|
GO:0042113 |
2 |
0.010
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.010
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
102 |
0.010
|
|